This inhibition can lead to excess cortisol, which stimulates mineralocorticoid receptors and results in symptoms similar to hyperaldosteronism, such as increased sodium retention, potassium loss, and high blood pressure. Here, NR3C2 is linked to hyperaldosteronism.